Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

GH

GPT Healthcare IPO

Listed MAINBOARD BSE, NSE · Hospital

Price Band

₹177.0–186.0

Issue Size

₹525.14 Cr

Lot Size

80 shares

Min Investment

₹14,880

GMP

Grey Market Premium — the unofficial premium buyers are currently willing to pay over the issue price once this IPO lists. It's an informal market estimate, not guaranteed, and can move daily right up to listing day. Learn more: GMP vs Kostak vs Sauda →

+₹17.0 (9.14%)

Issue Price

₹186.0

Subject to Sauda

A separate grey-market deal made before allotment is known: a buyer agrees to pay you this amount for your IPO application — but only if you actually get allotted shares. No allotment means no payment either way. This is different from "Kostak," a similarly-named rate that's paid regardless of whether the application gets allotted — TopFund shows the Sauda rate because that's what our data source provides. Learn more: GMP vs Kostak vs Sauda →

₹1000

Paid only if allotted

GPT Healthcare IPO AI Summary

  • GPT Healthcare IPO is listed on BSE, NSE in the Hospital sector.
  • Price band: ₹177.0–₹186.0 per share, lot size 80 shares (min. investment ₹14,880).
  • Subscription window: 22 Feb–26 Feb 2024, listing on 29 Feb 2024.
  • Current GMP is +₹17.0 (9.14%), an estimated listing price of ₹203 — unofficial and can change daily.

GPT Healthcare Limited is an established player in the healthcare sector with a focus on multi-specialty hospitals in Eastern India. The company's financial performance shows growth in revenue and profit over the past few years, although recent figures indicate a decline in the latest reporting period. The IPO offers an opportunity for investors to participate in the healthcare sector, with a moderate GMP suggesting potential listing gains.

TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.

GPT Healthcare IPO — Third-Party Research Views

Reviews below reflect analyst calls made before this IPO closed on 26 Feb 2024 — not a current signal.

7 of 8 reviewers say Positive

Subscribe 25 Jul
May Apply 25 Jul
May Apply 25 Jul
Subscribe 25 Jul
Subscribe 25 Jul
Subscribe 25 Jul
Neutral 25 Jul
Subscribe 25 Jul

Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.

Important Dates

IPO Open Date
Thu, 22 Feb 2024
IPO Close Date
Mon, 26 Feb 2024
Allotment Date
Tue, 27 Feb 2024
Refund Initiation
Wed, 28 Feb 2024
Credit of Shares
Wed, 28 Feb 2024
Listing Date
Thu, 29 Feb 2024
Listing Price
₹203.0 +9.14%

Subscription Status

Subscription data unavailable

GPT Healthcare IPO Grey Market Premium (GMP) Today

GMP

+₹17.0

GMP %

+9.14%

Est. Listing

₹203.0

Updated: 25 Jul 2026 14:07

About the Company

Incorporated in 1989, GPT Healthcare Limited operates a chain of mid-sized, multi-specialty, full-service hospitals in Eastern India under the ILS Hospitals brand, providing integrated healthcare services focusing on secondary and tertiary care. Based in Kolkata, West Bengal, the company offers a range of healthcare services in over 35 specialties and super-specialties, including internal medicine and diabetology, nephrology (including kidney transplant), laparoscopic and general surgery, gynaecology and obstetrics, intensive care, gastroenterology, orthopaedics and joint replacement, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology. It also offers integrated diagnostic services and pharmacies. GPT Healthcare's hospitals are located in four cities, namely Salt Lake, Kolkata (West Bengal) with a capacity of 85 beds, including 17 beds in various ICUs and HDUs (as of June 30, 2023) Agartala (Tripura) with a capacity of 205 beds (as of June 30, 2023), including 66 beds in various ICUs and HDUs Dum Dum, Kolkata (West Bengal) with a capacity of 155 beds, including 53 beds in various ICUs and HDUs as of June 30, 2023 Howrah (West Bengal) with a capacity of 116 beds, including 43 beds in various ICUs and HDUs, as of June 30, 2023. As at June 30, 2023, the company operates four multidisciplinary hospitals with a total capacity of 561 beds, offering a comprehensive range of healthcare services in over 35 specialties and super-specialties. As at June 30, 2023, the company had 1,855 employees, 85 full-time consultants, and 465 visiting consultants.

Company Financials (₹ Cr)

As of 2023-09-30

Period Ended 30 Sep 2023 31 Mar 2023 31 Mar 2022 31 Mar 2021
Assets 332.09 326.76 323.22 317.21
Total Income 206.70 366.73 342.40 248.86
Profit After Tax 23.49 39.01 41.66 21.09
NET Worth 171.43 164.14 156.96 132.68
Reserves and Surplus 92.75 85.46 78.28 75.96
Total Borrowing 55.57 64.67 95.52 122.93

Key Ratios

EPS

₹4.88

NAV

₹20.54

ROE

23.59%

ROCE

26.09%

RoNW

23.77%

P/B Value

9.06

P/E Ratio

38.1

Market Cap

₹1526.22 Cr

PAT Margin

10.64%

Debt/Equity

0.39

Peer Comparison

Company NAV RoNW P/E (x) EPS Basic EPS Diluted
Shalby Ltd 85.54 7.33% 49.01 6.31 6.27
Kovai Medical Center & Hospital Ltd. 656.65 16.11% 29.93 105.8 105.8
Yatharth Hospital & Trauma Care Services Limited 27.84 36.06% 37.66 10.09 10.09
Jupiter Life Line Hospitals Ltd 64.7 19.94% 81.73 13.95 12.95
Krishna Institute Of Medical Sciences Limited 206.47 20.35% 49.51 42.03 42.03
Global Health Limited 89.65 13.56% 90.29 12.58 12.57
GPT Healthcare Limited This IPO 20.54 23.77% 38.1 4.88 4.88

Promoters

GPT Sons Pvt.Ltd., Dwarika Prasad Tantia, Om Tantia and Shree Gopal Tantia

Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company from banks and financialinstitutions 30.00 2 General corporate purpose 7.52

IPO Evaluation

Generated 23 Sep 2026

Revenue Trend

Total income was ₹248.86 Cr in the period ending 31 Mar 2021, increasing to ₹342.40 Cr by 31 Mar 2022, and further rising to ₹366.73 Cr by 31 Mar 2023. However, in the most recent period ending 30 Sep 2023, total income decreased to ₹206.70 Cr, though this is a 6-month figure, not a full year, so isn't directly comparable.

Profit Trend

Profit After Tax was ₹21.09 Cr in the period ending 31 Mar 2021, increasing to ₹41.66 Cr by 31 Mar 2022, and then to ₹39.01 Cr by 31 Mar 2023. In the latest period ending 30 Sep 2023, profit after tax was ₹23.49 Cr, though this is a 6-month figure, not a full year, so isn't directly comparable.

Valuation

At the issue price of ₹186, GPT Healthcare's implied P/E ratio is approximately 38.1 times its earnings per share of ₹4.88. This is in comparison to peers trading at P/E ratios ranging from 29.93 to 90.29.

Grey Market Premium, Explained

The grey market refers to the unofficial trading of shares before they are listed on the stock exchange. The Grey Market Premium (GMP) indicates the expected listing price of the IPO shares compared to the issue price. A positive GMP suggests that the shares may list at a premium, while a negative GMP indicates the opposite.

Who This IPO Suits

Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy, considering factors such as the company's financial health, market position, and growth potential.

Who May Want to Wait

Investors who prefer stable, established companies with predictable earnings may want to avoid IPOs like this, which can be subject to market fluctuations and uncertainties.

Listing Gains — The Risk

Listing gains are the profits made when shares are sold on the listing day at a price higher than the issue price. However, these gains are not guaranteed and can be influenced by market conditions, investor sentiment, and overall demand for the stock.

This evaluation is generated from GPT Healthcare's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.

Frequently Asked Questions

What is GPT Healthcare IPO GMP today?

GPT Healthcare IPO GMP today is +₹17.0 (9.14%), indicating an estimated listing price of ₹203. GMP is an unofficial grey-market indicator and can change daily.

What is the price band of GPT Healthcare IPO?

The price band of GPT Healthcare IPO is ₹177.0–₹186.0 per share.

When does GPT Healthcare IPO open and close?

GPT Healthcare IPO opens on 22 February 2024 and closes on 26 February 2024.

When does GPT Healthcare IPO list on the stock exchange?

GPT Healthcare IPO listed on 29 February 2024 at ₹203.0.

What is the lot size for GPT Healthcare IPO?

The lot size for GPT Healthcare IPO is 80 shares, requiring a minimum investment of ₹14,880.

What is the price band for the IPO?

The price band for the IPO is ₹177 to ₹186.

What is the minimum investment required?

The minimum investment required is ₹14,880, which corresponds to a lot size of 80 shares.

When does the IPO open and close?

The IPO opens on February 22, 2024, and closes on February 26, 2024.

What does GMP mean?

GMP stands for Grey Market Premium, which indicates the expected premium at which the shares might list compared to the issue price.

When is the listing date?

The listing date for the IPO is February 29, 2024.

Issue Details

Issue Type MAINBOARD Book Built
Issue Size ₹525.14 Cr
Price Band ₹177.0 – ₹186.0
Issue Price ₹186.0
Lot Size 80 shares
Min Investment ₹14,880
Exchange BSE, NSE
Sector Hospital
Open Date 22 Feb 2024
Close Date 26 Feb 2024
Allotment 27 Feb 2024
Listing Date 29 Feb 2024

Investor Allocation

QIB (Institutional) 50%
NII / HNI 15%
Retail (RII) 35%

Registrar

MUFG Intime India Pvt.Ltd.

Lead Managers / Book Running

JM Financial Ltd.

IPO Timeline

Open

22 Feb 2024

Close

26 Feb 2024

Allotment

27 Feb 2024

Listing

29 Feb 2024

Community Sentiment

What are other investors planning for GPT Healthcare?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.